VeriMomginkgo biloba leaf powder est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification for Ginkgo biloba leaf (ECHA Annex VI). No SCCS or CIR safety assessment identifying reproductive hazards for topical use; available animal reproductive signals are from high‑dose oral exposures to extracts (PubMed) and do not establish a topical reproductive hazard. Dermal absorption from a cosmetic powder formulation is expected to be negligible, so systemic exposure in pregnancy from topical use is minimal (ECHA registration dossiers/PubChem for composition; PubMed for oral studies).
Pregnancy-safe products containing ginkgo biloba leaf powder
Related ingredients
Frequently asked questions
- ginkgo biloba leaf powder est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification for Ginkgo biloba leaf (ECHA Annex VI). No SCCS or CIR safety assessment identifying reproductive hazards for topical use; available animal reproductive signals are from high‑dose oral exposures to extracts (PubMed) and do not establish a topical reproductive hazard. Dermal absorption from a cosmetic powder formulation is expected to be negligible, so systemic exposure in pregnancy from topical use is minimal (ECHA registration dossiers/PubChem for composition; PubMed for oral studies).
- ginkgo biloba leaf powder est-il sûr pendant l'allaitement ?
- No harmonised classification or authoritative cosmetic‑safety body (CIR/SCCS) conclusion indicating risk to lactation or breastfed infants from topical use. Systemic transfer via breastmilk is unlikely from low dermal exposure to a topical powder; oral high‑dose animal data do not translate to typical cosmetic use (PubMed, ECHA/CosIng).
- ginkgo biloba leaf powder est-il sûr pour la peau de bébé ?
- Hazard and mechanism: no authoritative evidence of reproductive/developmental toxicity relevant to infant topical exposure (h=0, m=0). Exposure: increased by +1 for baby skin (e=1) because infants have an immature barrier and higher surface‑area‑to‑weight—if the ingredient has any measurable dermal absorption, infant exposure is higher than adult. There are no infant‑specific safety studies for topical Ginkgo biloba leaf powder in cosmetic products to demonstrate otherwise (PubMed/CosIng/ECHA).
- Comment VeriMom évalue-t-il ginkgo biloba leaf powder ?
- VeriMom évalue ginkgo biloba leaf powder à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à ginkgo biloba leaf powder pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à ginkgo biloba leaf powder basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.